Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-8.42	-6.28	-5.57	-3.51	-3.34	-3.54
Depreciation & Amortization	5.95	5.77	5.33	4.61	4.75	4.4
Share-Based Compensation	0.35	0.37	0.45	0.74	1.05	1.49
Other Operating Activities	7.49	6.24	8.25	4.5	2.96	0.7
Operating Cash Flow	5.38	6.09	8.45	6.34	5.42	3.06
Operating Cash Flow Growth	-25.19%	-27.91%	33.28%	17.13%	77.17%	-1.81%
Capital Expenditures	-0.34	-0.45	-2.07	-0.35	-2.11	-1.02
Acquisitions	0	0	-12.5	0	0	-5
Change in Investments	0	0	0	-0.2	0	8.32
Other Investing Activities	0.35	0.35	0.9	0.05	0.36	-
Investing Cash Flow	0.01	-0.11	-13.67	-0.5	-1.76	2.3
Share Issuance / Repurchase	-0.8	-0.74	-1.05	-1.39	-1.85	-3.49
Debt Issued / Paid	0.01	-3.42	1.2	0	-3.51	-1.55
Other Financing Activities	-2.43	-3.27	-2.21	-2.17	-1.75	-0.03
Financing Cash Flow	-3.22	-7.42	-2.06	-3.55	-7.12	-5.08
Net Cash Flow	2.16	-1.44	-7.28	2.29	-3.46	0.27
Free Cash Flow	5.04	5.64	6.38	5.99	3.3	2.04
Free Cash Flow Growth	1.19%	-11.58%	6.54%	81.39%	62.04%	-
Free Cash Flow Margin	12.98%	14.26%	15.19%	16.64%	8.82%	5.92%
Free Cash Flow Per Share	0.36	0.39	0.44	0.40	0.22	0.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).